Anti-lung cancer effect of paclitaxel solid lipid nanoparticles delivery system with curcumin as co-loading partner in vitro and in vivo
Authors:
Open Access
- 24 June 2022
- journal article
- research article
- Published by Taylor & Francis in Drug Delivery
- Vol. 29 (1) , 1878-1891
Abstract
The main aim of this study was to improve the therapeutic potential of a paclitaxel (PTX) and curcumin (CU) combination regimen using solid lipid nanoparticles (SLNs). PTX and CU were successfully co-encapsulated at a predetermined ratio in SLNs (PC-SLNs) with high encapsulation efficiency (CU: 97.6%, PTX: 95.8%), appropriate particle size (121.8 ± 1.69 nm), small PDI (0.267 ± 0.023), and negative zeta potential (–30.4 ± 1.25 mV). Compared with PTX or the combination of CU and PTX (CU + PTX), PC-SLNs can greatly reduce the dose of PTX while still achieving the same therapeutic effect on four cancer cell lines, among which the inhibitory effect on A549 lung cancer cells was the strongest. PC-SLNs improved the area under the curve (CU: 1.40-fold; PTX: 2.88-fold), prolonged the residence time (CU: 6.94-fold; PTX: 2.51-fold), and increased the half-life (CU: 5.62-fold; PTX: 6.46-fold), achieving long circulation. PC-SLNs were used to treat lung cancer in a nude mouse xenograft tumor model and the tumor suppression rate reached 78.42%, while those of PTX and (CU + PTX) were 40.53% and 51.56%, respectively. As PC-SLNs can prevent P-glycoprotein efflux, reverse MDR and downregulate the NF-κB pathway. PC-SLNs are a potential antineoplastic agent that is more effective and less toxic in treating lung cancer.Keywords
Funding Information
- the Cooperative Scientific Research Project of Chunhui Plan of the Ministry of Education of China (2020-703)
- the Youth Science and Technology Innovation Research Team (2021JDTD0008)
- the Youth Science and Technology Innovation Research Team (2020YJ0336)
- the Youth Science and Technology Innovation Research Team (2020YJ0373)
- Science and Technology Innovation Team from Jiucheng Science and Technology Talent Cultivation Plan in Luzhou City (No. 2019-1).)
- Key Research and Development Projectors of Office of Science & Technology and Talent Work of Luzhou (No. 2021-SYF-26)
- The Basic Research Fund of the Science and Technology Department of Sichuan province of China
This publication has 64 references indexed in Scilit:
- Targeting PI3K/AKT/mTOR pathway in non small cell lung cancerBiochemical Pharmacology, 2014
- Functional Nanostructures for Effective Delivery of Small Interfering RNA TherapeuticsTheranostics, 2014
- A comparative in vitro evaluation of self-assembled PTX-PLA and PTX-MPEG-PLA nanoparticlesDiscover Nano, 2013
- Poly (ethylene)-glycol conjugated solid lipid nanoparticles of noscapine improve biological half-life, brain delivery and efficacy in glioblastoma cellsNanomedicine: Nanotechnology, Biology and Medicine, 2013
- Paclitaxel-Induced Apoptosis Is BAK-Dependent, but BAX and BIM-Independent in Breast TumorPLOS ONE, 2013
- Akt is upstream and MAPKs are downstream of NF-κB in paclitaxel-induced survival signaling events, which are down-regulated by curcumin contributing to their synergismThe International Journal of Biochemistry & Cell Biology, 2011
- Localized delivery of paclitaxel using elastic liposomes: Formulation development and evaluationDrug Delivery, 2011
- Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effectEuropean Journal of Pharmaceutics and Biopharmaceutics, 2009
- In vivo maintenance of synergistic cytarabine:daunorubicin ratios greatly enhances therapeutic efficacyLeukemia Research, 2009
- Optimizing Combination Chemotherapy by Controlling Drug RatiosMolecular Interventions, 2007